Form D · Venture Capital Fund

China Life Sciences Access Fund, L.P.

Grand Cayman, E9 · CIK 0001570303

Offering snapshot reported Feb 27, 2013 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 27, 2013	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06, 3C, 3C.1, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-192471

Source: Form D, filed Feb 27, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CHINA LIFE SCIENCES ACCESS FUND, L.P.

Investment adviser: FRONTLINE BIOVENTURES (HONG KONG) LIMITED

Gross asset value: $22.2M
Beneficial owners: 22
ADV minimum commitment: $500K

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ELEVATE FINANCIAL SOLUTIONS, LLC SANTA CLARA, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor DELOITTE & TOUCHE GRAND CAYMAN, Cayman Islands

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: No
Administrator other than the adviser: Yes
External marketing: No

DELOITTE & TOUCHE
PCAOB 1096

Filing source

Form ADV 2081826 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-8623199038

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Leon Chen	Director
N/A N/A China Life Sciences Access Fund Gp, Llc	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Maples Corporate Services Limited Ugland House, P.O. Box 309
Grand Cayman, E9, KY1-1104